| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342330A Compound pulse beat restoring tea formulation for relieving summer-heat, quenching thirst, relieving restlessness, strengthening heart and relaxing somasthenia |
| 01/14/2009 | CN101342193A Method for fattening pig with albumen injection |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 01/14/2009 | CN100451018C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/14/2009 | CN100450550C Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 01/14/2009 | CN100450547C Medicinal compositions for improving oral absorption |
| 01/14/2009 | CN100450513C Medicine used for traditional Chinese medical moxibustion therapy, and its preparing method |
| 01/14/2009 | CN100450492C Composition and its use |
| 01/14/2009 | CN100450478C Pharmaceutical composition |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/14/2009 | CN100450474C Physiological cooling compositions |
| 01/14/2009 | CN100450381C Face beaufifying forehead nourishing decoction and its preparation method |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476732 Nucleic acid encoding α chain of human IL-11 receptor |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476676 Administering to the mammal an effective amount of a GSK-3 beta (glycogen synthase kinase-3 beta) to promote bone formation and treat bone metabolic diseases such as osteoporosis |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476388 Gastrin, and a second dose of an epithelial growth factor; in vivo islet cell regeneration, preexisting diabetes, islet neogenesis |
| 01/13/2009 | CA2440186C Medicinal composition containing 1,3-thiazine derivative |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2397785C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/13/2009 | CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2385402C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 01/13/2009 | CA2337397C 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/13/2009 | CA2304704C Formulations and methods for reducing toxicity of antineoplastic agents |
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/13/2009 | CA2293372C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/13/2009 | CA2287907C Novel orally active iron (iii) chelators |
| 01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 01/13/2009 | CA2189762C Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009005613A2 Stable non-disintegrating dosage forms and method of making same |
| 01/08/2009 | WO2009005509A1 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| 01/08/2009 | WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach |
| 01/08/2009 | WO2009005123A1 INTERFERON-β PRODUCTION PROMOTER, AND METHOD FOR PRODUCTION THEREOF |
| 01/08/2009 | WO2009005095A1 Treatment of influenza |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009005033A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |
| 01/08/2009 | WO2009005002A1 Quinolone derivative |
| 01/08/2009 | WO2009005000A1 Composition for mucosal administration containing agent for accelerating mucosal absorption of peptide drug and administration method thereof |
| 01/08/2009 | WO2009004899A1 Sialidase inhibitor |
| 01/08/2009 | WO2009004792A1 Sulfonamide compound, and crystal thereof |
| 01/08/2009 | WO2009003694A2 Method for treating diseases related to mitochondrial dysfunction |
| 01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
| 01/08/2009 | US20090012494 Intradermal delivery of biological agents |
| 01/08/2009 | US20090012166 Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These |
| 01/08/2009 | US20090012164 Pinolenic acid compositions, products made thereof, and methods of making pinolenic acid compositions and products |
| 01/08/2009 | US20090012162 Composition for treating or preventing cell degeneration using at least one molecule capable of maintaining adhesion molecule expression reversibility and vascular endothelium actin fibre polymerisation |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012141 Composition and Method for Making Oligo-Benzamide Compounds |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012042 Hydroxypropyl-Sulfobutyl-Beta-Cyclodextrin, the Preparation Method, the Analytical Method, and the Pharmacutical Application Thereof |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012033 Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers) |
| 01/08/2009 | US20090012019 Methods and Compositions Related to TR4 |
| 01/08/2009 | US20090012016 Short Interfering Rna and Micro-Rna Compounds and Methods of Designing, Making, and Using the Same |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 01/08/2009 | US20090011984 Biotin-binding receptor molecules |
| 01/08/2009 | US20090011983 186 Human Secreted Proteins |
| 01/08/2009 | US20090011982 Flagellin Related Polypeptides and Uses Thereof |
| 01/08/2009 | US20090011975 Targeted bone marrow protection agents |
| 01/08/2009 | US20090011060 Campsiandra angustifolia extract and methods of extracting and using such extract |
| 01/08/2009 | US20090011035 Personal care composition |
| 01/08/2009 | US20090011033 Process for the manufacture of cellulose sulfate with improved characteristics |
| 01/08/2009 | US20090011021 Engineered Extracellular Matrices |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090010991 Nasal Passage Stent |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010959 Complex containing diphtheria toxins |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | US20090010920 Fc Variants Having Decreased Affinity for FcyRIIb |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010899 Methods related to surgery |
| 01/08/2009 | US20090010896 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| 01/08/2009 | US20090010891 Sepsis Treatment Agent |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010838 Pyridylacetylenes for Use as Radiotracers and Imaging Agents |
| 01/08/2009 | DE102007031748A1 Miracle pyramid for intensive cleaning of body, mind and soul by incense resin or essential oils, is made by putting together tubes, which form tetrahedron |
| 01/08/2009 | CA2692478A1 Treatment of influenza |
| 01/08/2009 | CA2692265A1 Amide compounds |